Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07404982 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reversal of Spinal Anesthesia Residual Motor Block Via Intrathecal Catheter

Study acronym: IT-Cath
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment increased: 20 → 24 participants Eligibility criteria expanded, about 12 words · Study description shortened, about 7 words · Site contact updatedv3 Show 3 more changesShow less
    • Eligibility criteria expanded, about 12 words
    • Study description shortened, about 7 words
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  2. Start date changed from estimate of Feb 2026 to Mar 19, 2026 Site contact updatedv2 Show 1 more changeShow less
    • Site contact updated
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the feasibility of administering a predetermined amount of normal saline into the intrathecal or subarachnoid space via a small spinal catheter to reduce or eliminate the effects of previously injected spinal anesthetic following lower extremity orthopedic surgery.
Trial Details
NCT Number NCT07404982
Lead Sponsor Beth Israel Deaconess Medical Center
Conditions Joint Replacement Surgery
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov